Gut microbiome analysis in pancreatic cancer patients treated with 1-kestose
This study aims to evaluate the effects of 1-kestose supplementation on gut microbiota composition and nutritional status in patients with unresectable advanced pancreatic cancer undergoing chemotherapy. Fecal samples were collected before and after intervention and analyzed using 16S rRNA gene sequencing to investigate microbial diversity, taxonomic composition, and functional pathways. This dataset provides insights into microbiome modulation as a potential supportive strategy in cancer treatment.